STOUGHTON, Mass. (AP) — STOUGHTON, Mass. (AP) — Collegium Pharmaceutical Inc. (COLL) on Thursday reported third-quarter earnings of $9.3 million.
On a per-share basis, the Stoughton, Massachusetts-based company said it had profit of 27 cents. Earnings, adjusted for one-time gains and costs, came to $1.61 per share.
The results fell short of Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for earnings of $1.66 per share.
The specialty pharmaceutical company posted revenue of $159.3 million in the period, also falling short of Street forecasts. Four analysts surveyed by Zacks expected $160 million.
Collegium Pharmaceutical expects full-year revenue in the range of $620 million to $635 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on COLL at https://www.zacks.com/ap/COLL
Copyright © 2024 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
